Publications

Quantitation and Identification of Thousands of Human Proteoforms below 30 kDa.

Authors: KR Durbin, L Fornelli, RT Fellers, PF Doubleday, M Narita, NL Kelleher

Research group: Narita Group

E-pub date: 4 Mar 2016

Journal name: J Proteome Res

Methanol-based fixation is superior to buffered formalin for next-generation sequencing of DNA from clinical cancer samples.

Authors: AM Piskorz, D Ennis, G Macintyre, TE Goranova, M Eldridge, N Segui-Gracia, ...

Research group: Brenton Group, Bioinformatics

E-pub date: 1 Mar 2016

Journal name: Ann Oncol

Intensive cisplatin/oral etoposide for epithelial ovarian cancer: the Cambridge Gynae-Oncology Centre experience: too toxic for relapse?

Authors: I Gounaris, M Iddawela, C Parkinson, J Pratt, H Hatcher, B Basu, LT Tan, JD...

Research group: Brenton Group

E-pub date: 1 Mar 2016

Journal name: Anticancer Drugs

MRI with hyperpolarised [1-13C]pyruvate detects advanced pancreatic preneoplasia prior to invasive disease in a mouse model.

Authors: EM Serrao, MI Kettunen, TB Rodrigues, P Dzien, AJ Wright, A Gopinathan, FA ...

Research group:

E-pub date: 1 Mar 2016

Journal name: Gut

Decline in Antigenicity of Tumor Markers by Storage Time Using Pathology Sections Cut From Tissue Microarrays.

Authors: FM Blows, HR Ali, S-J Dawson, J Le Quesne, E Provenzano, C Caldas, PDP Phar...

Research group: Ali Group

E-pub date: 1 Mar 2016

Journal name: Appl Immunohistochem Mol Morphol

1067 SIK2 is a novel secreted protein associated with a malignant phenotype in prostate cancer

Authors: K Wadhwa, H Bon, K Holmes, A Warren, H Whittaker, J Kay, L Fryer, D Neal, V...

Research group: Carroll Group

E-pub date: 1 Mar 2016

Journal name: European Urology Open Science

A Happy 3′ Ending to the piRNA Maturation Story.

Authors: B Czech, GJ Hannon

Research group: Hannon Group

E-pub date: 25 Feb 2016

Journal name: Cell

Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer.

Authors: HR Ali, A Dariush, E Provenzano, H Bardwell, JE Abraham, M Iddawela, A-L Va...

Research group: Brenton Group, Ali Group

E-pub date: 16 Feb 2016

Journal name: Breast Cancer Res

Filters

Research Groups

Core Facilities

Start date

End date

Quantitation and Identification of Thousands of Human Proteoforms below 30 kDa.

Methanol-based fixation is superior to buffered formalin for next-generation sequencing of DNA from clinical cancer samples.

Intensive cisplatin/oral etoposide for epithelial ovarian cancer: the Cambridge Gynae-Oncology Centre experience: too toxic for relapse?

MRI with hyperpolarised [1-13C]pyruvate detects advanced pancreatic preneoplasia prior to invasive disease in a mouse model.

Decline in Antigenicity of Tumor Markers by Storage Time Using Pathology Sections Cut From Tissue Microarrays.

1067 SIK2 is a novel secreted protein associated with a malignant phenotype in prostate cancer

A Happy 3′ Ending to the piRNA Maturation Story.

Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer.

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Quantitation and Identification of Thousands of Human Proteoforms below 30 kDa.

Methanol-based fixation is superior to buffered formalin for next-generation sequencing of DNA from clinical cancer samples.

Intensive cisplatin/oral etoposide for epithelial ovarian cancer: the Cambridge Gynae-Oncology Centre experience: too toxic for relapse?

MRI with hyperpolarised [1-13C]pyruvate detects advanced pancreatic preneoplasia prior to invasive disease in a mouse model.

Decline in Antigenicity of Tumor Markers by Storage Time Using Pathology Sections Cut From Tissue Microarrays.

1067 SIK2 is a novel secreted protein associated with a malignant phenotype in prostate cancer

A Happy 3′ Ending to the piRNA Maturation Story.

Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer.